SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

09 Aug 2023 Evaluate
The sales slipped to Rs. 8210.00 millions for the June 2023 quarter as against Rs. 9213.57 millions during the year-ago period.A big decline of -36.01% was reported for the quarter ended June 2023 to Rs. 798.40  millions from Rs. 1247.68 millions of corresponding previous quarter.A decline of 1572.10 millions was observed in the OP in the quarter ended June 2023 from 2012.09 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 8210.00 9213.57 -10.89 8210.00 9213.57 -10.89 39312.00 32384.37 21.39
Other Income 4.36 45.48 -90.41 4.36 45.48 -90.41 99.32 175.11 -43.28
PBIDT 1572.10 2012.09 -21.87 1572.10 2012.09 -21.87 8481.71 6621.60 28.09
Interest 147.88 44.39 233.14 147.88 44.39 233.14 386.74 163.52 136.51
PBDT 1424.22 1967.70 -27.62 1424.22 1967.70 -27.62 8094.97 6458.08 25.35
Depreciation 352.67 345.99 1.93 352.67 345.99 1.93 1455.57 1261.61 15.37
PBT 1071.55 1621.71 -33.92 1071.55 1621.71 -33.92 6639.40 5196.47 27.77
TAX 273.15 374.03 -26.97 273.15 374.03 -26.97 1651.55 1331.31 24.05
Deferred Tax 17.54 -20.55 -185.35 17.54 -20.55 -185.35 -50.51 -3.76 1243.35
PAT 798.40 1247.68 -36.01 798.40 1247.68 -36.01 4987.85 3865.16 29.05
Equity 242.04 248.01 -2.41 242.04 248.01 -2.41 242.04 248.01 -2.41
PBIDTM(%) 19.15 21.84 -12.32 19.15 21.84 -12.32 21.58 20.45 5.52

Granules India Share Price

747.80 -8.55 (-1.13%)
12-May-2026 10:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1869.65
Dr. Reddys Lab 1277.00
Cipla 1298.20
Zydus Lifesciences 944.05
Lupin 2243.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×